jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Jan. 27, 2025

Mar. 31, 2026

jRCT2011240068

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer (SR0379-JP-SU-02)

A Phase 3 Study of SR-0379 in Participants with Skin Ulcer (SR0379-JP-SU-02)

Tomioka Hideki

FunPep Co., Ltd.

Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka

+81-6-6369-7957

htomioka@funpep.co.jp

Kasahara Satoru

FunPep Co., Ltd.

Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka

+81-6-6369-7957

skasahara@funpep.co.jp

Recruiting

Mar. 01, 2025

Mar. 18, 2025
142

Interventional

randomized controlled trial

double blind

placebo control

parallel assignment

treatment purpose

Patients with a skin ulcer requiring wound bed preparation before surgical intervention (sutures, skin grafts or pedicle flaps)

Patients with obvious infection at the ulcer site, such as redness or swelling around the ulcer, pus, foul odor, or fever

18age old over
85age old under

Both

skin ulcer

SR-0379 or placebo spray

Days to minor surgical intervention (sutures, skin grafts or pedicle flaps)

FunPep Co., Ltd.
Hakodate Central General Hospital Institutional Review Board
33-2, Hon-cho, Hakodate-city, Hokkaido, Hokkaido

+81-138-52-1231

kubota-y@hakochu-hp.gr.jp
Approval

Jan. 14, 2025

No

none

History of Changes

No Publication date
5 Mar. 31, 2026 (this page) Changes
4 Jan. 09, 2026 Detail Changes
3 April. 10, 2025 Detail Changes
2 Mar. 17, 2025 Detail Changes
1 Jan. 27, 2025 Detail